Brexpiprazole in Borderline Personality Disorder
Clinical trial NCT03418675 · COMPLETED
Trial details
- NCT number
- NCT03418675
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-26
- Primary completion
- 2020-12-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.